TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07089602: Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous

Sponsor: BioLab Holdings · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 650 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$8,499,200

Rescue Site Savings

+$5,604,160

Unlock Full NCT07089602 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07089602 Rescue Dossier →